2021-04-22 21:10 Currently, an estimated 285 million people worldwide suffer from hereditary, rare, age-related and degenerative eye diseases. The development of new treatments for eye diseases has brought more interest and opportunities. At CD BioSciences, we have extensive and comprehensive clinical research and development experience in numerous ophthalmic indications. Whether you are developing eye treatment equipment, drug delivery, or looking for a clinical development solution, our industry-leading expertise and experience will provide you from all stages of trial design to commercialization and beyond to maximize success of your ophthalmic clinical research.
Вы можете показать это желание на своем сайте, в блоге, в форуме и т.д., скопировав и вставив туда этот HTML-код.
